Table 1.

CSC markers reported in different human cancers

Cancer type	CSC markers
Leukemia	CD34+CD38^-, CD96⁺, ALDH⁺, CD47⁺, CD44⁺,CD123⁺, TIM-3⁺, CD32⁺ and CD25⁺, CLL-1⁺
Breast	CD44⁺CD24^-, PKH26⁺, CD49f^li, ALDH⁺, SP, CD133⁺, CD90^hi, CD44⁺CD49f^hiCD133/2^hi
Prostate	SP, ABCG2⁺, CD44⁺, ALDH⁺, CD44⁺α2β1^hi, CXCR4⁺ and CD133⁺, CD44⁺α2β1^hiCD133⁺, NANOG⁺, PSA^-/lo, CK187CK19^- (HLAI^-), TRA-1–60⁺CD151⁺CD166⁺, ALDH^hiCD44⁺α2β1⁺
Bladder	CD44⁺CK5⁺CK20^-, EMA^-CD44v6⁺, SP, 67LR⁺CD66c^-CK17⁺, ALDH⁺, SOX2⁺
Ovarian	ALDH⁺ and ALDH⁺CD133⁺, ALDH⁺ and CD44⁺, SP, CD117/c-kit⁺, CD44⁺ and MyD88⁺, CD24⁺, CD133⁺CXCR4⁺,
Colon	CD133⁺, CD44⁺, EpCAM^hiCD44⁺ and/or CD166⁺, ALDH⁺, SP, LGR5⁺, ABCB5⁺
Liver	CD133⁺, ALDH⁺, EpCAM⁺ and CD90⁺, CD45^-CD90⁺, CD133⁺CD44⁺,CD13⁺, ICAM-1⁺, SALL4⁺
Lung	SP, CD133⁺, ALDH⁺, CD117/c-kit⁺, OCT4/NANOG⁺, CD44⁺, TPBG/5T4⁺, CD166⁺, CD166⁺CD44⁺ and CD166⁺EpCAM⁺
Pancreatic	CD44v6⁺, α6β4⁺, TSPAN8⁺ and CXCR4⁺, CD44⁺CD24⁺ESA⁺, c-Met⁺, ALDH⁺, CD133⁺CXCR4⁺
Glioblastoma	CD133⁺, SP and ABCG2⁺, SSEA-1⁺, SOX2⁺, BMI1⁺ and MUSASHI1⁺, NESTIN⁺, OLIG2⁺, CD49f⁺, A2B5⁺CD133^-, L1CAM⁺, EGFR⁺, CD44⁺ and CD44^hiID1^hi, MYC⁺, ALDH⁺